Regutran 50mg Tablet

Regutran 50mg Tablet contains the active ingredient Topiramate, which belongs to the class of medications known as anticonvulsants. It is formulated as an oral tablet for the management of various neurological and psychiatric conditions.

Active Ingredient:

Topiramate: This medication is believed to work by increasing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, and by blocking voltage-gated sodium channels. It is thought to exert its anticonvulsant and mood-stabilizing effects through these mechanisms.

Uses:

Regutran 50mg Tablet is indicated for:

• Treatment of epilepsy (seizure disorders) in adults and children.
• Prevention of migraine headaches in adults.
• Adjunctive therapy in the treatment of partial-onset seizures in patients with epilepsy.

Mechanism of Action:

Topiramate’s precise mechanism of action is not fully understood. However, it is believed to work by enhancing the activity of GABA, thereby inhibiting neuronal excitability and reducing the spread of abnormal electrical activity in the brain. It also blocks voltage-gated sodium channels, which may contribute to its anticonvulsant effects.

Administration:

Take Regutran 50mg Tablet orally, with or without food, as directed by a healthcare professional. The dosage and duration of treatment may vary depending on the specific condition being treated and individual patient factors.

Side Effects:

Common side effects of Regutran 50mg Tablet may include:

• Dizziness or drowsiness
• Fatigue or weakness
• Nervousness or anxiety
• Difficulty concentrating
• Nausea or vomiting
• Weight loss or appetite changes

Precautions:

• Inform your healthcare provider about any history of kidney stones, metabolic disorders, or mood disorders before starting Topiramate.
• Use caution when driving or operating machinery, as Topiramate may cause dizziness, drowsiness, or vision changes.
• Avoid abrupt discontinuation of Topiramate, as it may increase the risk of seizures.

When Not to Use:

Regutran 50mg Tablet is contraindicated in patients with a known hypersensitivity to Topiramate or any components of the tablet. It should not be used in patients with metabolic acidosis or in those with a history of kidney stones.